Abiomed
ABMD
#1108
Rank
NZ$29.28 B
Marketcap
$649.41
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Revenue for Abiomed (ABMD)

Revenue in 2022 (TTM): NZ$1.67 Billion

According to Abiomed's latest financial reports the company's current revenue (TTM ) is NZ$1.83 Billion. In 2021 the company made a revenue of NZ$1.46 Billion an increase over the revenue in the year 2020 that were of NZ$1.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abiomed from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) NZ$1.67 B14.24%
2021 NZ$1.46 B30.35%
2020 NZ$1.12 B-9.81%
2019 NZ$1.24 B13.73%
2018 NZ$1.09 B43.4%
2017 NZ$0.76 B27.98%
2016 NZ$0.59 B35.13%
2015 NZ$0.44 B62.78%
2014 NZ$0.27 B26.41%
2013 NZ$0.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$5.15 B 181.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.95 B 1,317.75%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.76 B-58.33%๐Ÿ‡บ๐Ÿ‡ธ USA